DelveInsight

DelveInsight operates through Delveinsight Business Research Llp (active). Its filings, financials, charges and directors are on the company page.

Delveinsight Business Research Llp is the primary company behind DelveInsight. The board of Delveinsight Business Research Llp currently have 3 directors; the longest-serving is Birendra Kumar Agrawal, appointed in 2014. 2 earlier directors have ceased.

11 people are tracked at DelveInsight (3 in leadership, 3 in board & advisors, 5 in team); the tracked headcount is 81.

Figures of Delveinsight Business Research Llp, the primary company behind DelveInsight, for FY 2021. Revenue was ₹14.30 Cr (+79% year on year). EBITDA was ₹2.31 Cr (16% margin). Revenue has grown at a compounded annual rate of +67% over three years and +80% over five years.

• ₹14.30 CrRevenue · FY 2021 · +79% YoY
• ₹2.31 CrEBITDA · 16% margin
• 110Employees (provident fund records)
• +67%Revenue CAGR, 3 years
• +80%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Delveinsight Business Research Llp are on its company page.

The website of DelveInsight (delveinsight.com) receives about 65.1K visits a month and ranks #743,647 among all websites worldwide, #861 in Biotechnology and Pharmaceuticals.

• Monthly visits
  65.1K

  ▲ 35.1% vs previous month

• Unique visitors
  22.3K

  per month

• Global rank
  #743,647

  among all websites

• Category rank
  #861

  Health · Biotechnology and Pharmaceuticals

Websites whose visitors overlap most with DelveInsight. Affinity shows how closely the audiences match.

Website	Domain	Audience affinity	Monthly visits	Global rank	Profile
towardshealthcare.com	towardshealthcare.com	100%	–	#946,707	–
clinicaltrials.eu	clinicaltrials.eu	97%	–	#508,977	–
ipi.academy	ipi.academy	96%	–	#1,399,825	–
Biomapas	biomapas.com	89%	680.7K	#2,569,977	View details
bioinformant.com	bioinformant.com	89%	–	#761,820	–
••••••••••	••••••.com	••%	•.•M	#•••••	–
••••••••••	••••••.com	••%	•.•M	#•••••	–
••••••••••	••••••.com	••%	•.•M	#•••••	–

10 companies that operate in the same segment as DelveInsight (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.

Company	Description	Founded	Location	Total funding	Revenue	Employees
Merck	Pharmaceutical products are manufactured and marketed worldwide.	1891	Kenilworth, Warwickshire, United Kingdom	–	USD 64.93 B	781
Roivant Sciences	Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed.	2014	New York, New York, United States	USD 1.3 B	USD 8.26 M	750
Amgen	Developer of pharmaceutical products for treating multiple diseases	1980	Thousand Oaks, California, United States	–	USD 33.23 B	28,000
AbbVie	Biopharmaceutical research and drug development are conducted globally by AbbVie.	2012	Chicago, Illinois, United States	–	USD 61.16 B	55,000
Lilly	Traditional pharmaceutical medicines are developed for multiple health fields.	1876	United States	–	USD 65.18 B	47,000
Gilead	Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others	1987	Foster City, California, United States	–	USD 29.45 B	17,600
Recursion Pharmaceuticals	Novel therapeutics are discovered using an AI-enabled drug platform.	2013	New York, New York, United States	USD 456.66 M	USD 74.68 M	–
FibroGen	Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology.	1993	San Francisco, California, United States	USD 215.5 M	USD 29.62 M	225
Abbott	Developer of medical devices, generic pharmaceuticals, and nutrition products	1888	Libertyville, Illinois, United States	–	USD 44.33 B	3,710
MedPlus	Medicines and health products are retailed through pharmacy outlets.	2006	Hyderabad, Telangana, India	USD 268.78 M	USD 734.57 M	25,010